Ebola and Marburg fevers - Annual Epidemiological Report for 2017
For 2017, no cases of Ebola virus disease and Marburg haemorrhagic fever were reported in the EU/EEA.
Hantavirus infection - Annual Epidemiological Report for 2017
In 2017, 21 countries reported 4 239 cases of hantavirus infection (0.8 cases per 100 000 population). Two countries, Finland and Germany, accounted for 70.1% of all reported cases. In the absence of a licensed vaccine, prevention mainly relies on rodent control, avoidance of contact and properly cleaning and disinfecting areas contaminated by rodent excreta (urine, saliva or droppings).
Tularaemia - Annual Epidemiological Report for 2017
For 2017, 447 cases of tularaemia were reported by 18 countries in the EU/EEA, 413 (92%) of which were confirmed. As in previous years, the proportion of cases among males was higher in all age groups, with a male-to-female ratio of 2.1:1. Notification rates in men and women increased with age (except for the age group ≥65 years). The highest rate was observed in men in the age group 45–64 years (0.2 cases per 100 000 population).
Syphilis - Annual Epidemiological Report for 2017
In 2017, 33 189 confirmed syphilis cases were reported in 28 EU/EEA Member States. Reported syphilis rates were nine times higher in men than in women and peaked among 25–34-year-old men. Two-thirds of syphilis cases with information on transmission category were reported in men who have sex with men. The trend in syphilis rates has been on the rise since 2011, particularly among men, mainly due to an increase in the number of cases among MSM. The slight increase of syphilis rates among women, seen already in 2016, continued in 2017.
Communicable disease threats to public health in the European Union - Annual Epidemiological Report for 2018
This report covers the events and threats detected by the ECDC epidemic intelligence (EI) team in 2018 and the actions taken related to these findings.
Tetanus - Annual Epidemiological Report for 2017
In 2017, 82 cases of tetanus, including 46 confirmed cases, were reported in the EU/EEA. Adults aged 65 years and above were the most affected age group, with females accounting for the majority of the cases. Cases tended to occur more frequently in the warmer months, which are associated with higher levels of outdoor activity. The current epidemiology of tetanus in the EU/EEA may be explained by lower vaccination coverage or waning immunity in older populations. Due to the severity of tetanus, there is a need to maintain high vaccination rates in all age groups and continue implementing/developing strategies to protect specific groups, particularly the elderly, in countries with higher rates of disease.
Diphtheria - Annual Epidemiological Report for 2017
For 2017, 39 cases of diphtheria due to toxigenic Corynebacterium diphtheriae or C. ulcerans were reported to ECDC. The highest proportion of C. ulcerans cases was among adults 45 years of age and above, whereas C. diphtheriae cases were more common in younger age groups. Among C. diphtheriae cases, 50% were reported as imported. High vaccination coverage is crucial to prevent diphtheria.
Congenital toxoplasmosis – Annual Epidemiological Report for 2016
In 2016, 242 confirmed cases of congenital toxoplasmosis were reported in the EU/EEA, with France accounting for 81% of all confirmed cases due to the active screening of pregnant women. The notification rate was 6.7 cases per 100 000 live births. No seasonal pattern was observed for the disease.
Brucellosis – Annual Epidemiological Report for 2017
In 2017, 381 confirmed brucellosis cases were reported in the EU/EEA. The notification rate in the EU/EEA was 0.09 cases per 100 000 population. The highest rates were reported in southern EU Member States (Greece, Italy and Portugal). The highest rate was observed in 25–44-year-old males (0.16 per 100 000). The notification rate was stable from 2013–2017 in the EU/EEA.
Hepatitis B - Annual Epidemiological Report for 2017
In 2017, 30 EU/EEA Member States reported 26 907 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases, 26 262, corresponds to a crude rate of 6.7 cases per 100 000 population.